Viskase Holdings Inc Asset Turnover Ratio (ENZN), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Viskase Holdings inc   (ENZN)
 

Viskase Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Viskase Holdings Inc 's asset turnover ratio sequentially decreased to 0.58 in the second quarter (Jun 30 2026), but remained above the company's average. For every Dollar on the Balance Sheet, Viskase Holdings Inc realized $0.58 in annual sales.

Within sector 16 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2389, from total ranking in the first quarter 2026 at 4474.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENZN Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 1548.38 % 842.15 % -79.95 % -7.58 % -4.71 %
Y / Y Revenue Change 17890.22 % 17203.82 % - -24.16 % 1826.92 %
Asset Turnover Ratio (TTM) 0.58 0.66 0.05 0.03 0.04
ENZN's Total Ranking # 2389 # 4474 # 3569 # 3584 # 3784
Seq. Asset Change 72.11 % 4435.47 % -78.36 % -2.43 % -1.63 %
Seq. Revenue Change 4.8 % 20040.52 % -13.91 % -1 % 0.8 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 265
Overall Market # 2389

Asset Turnover Ratio Statistics
High Average Low
2.15 0.42 -0.02
(Mar 31 2014)   (Sep 30 2018)




ENZN Company Profile • Back to ENZN Efficiency Comparisons • Compare ENZN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Resmed Inc   0.66 $ 5,628.170  Millions$ 8,558.245  Millions
Align Technology inc   0.66 $ 4,138.567  Millions$ 6,299.750  Millions
Twist Bioscience Corporation  0.66 $ 431.798  Millions$ 658.093  Millions
Eli Lilly And Company  0.66 $ 79,665.800  Millions$ 121,567.600  Millions
Anika Therapeutics Inc   0.65 $ 121.370  Millions$ 185.642  Millions
Agenus Inc  0.65 $ 132.693  Millions$ 204.959  Millions
Gyre Therapeutics Inc   0.64 $ 119.383  Millions$ 185.104  Millions
Logicmark Inc  0.64 $ 12.544  Millions$ 19.555  Millions
Strata Critical Medical Inc   0.64 $ 211.642  Millions$ 330.217  Millions
Castle Biosciences Inc   0.64 $ 357.278  Millions$ 562.581  Millions
Vericel Corporation  0.63 $ 306.303  Millions$ 482.434  Millions
Bridgebio Pharma Inc   0.63 $ 713.069  Millions$ 1,130.639  Millions
Ss Innovations International Inc  0.63 $ 52.199  Millions$ 82.833  Millions
Zoetis Inc   0.63 $ 9,517.000  Millions$ 15,214.250  Millions
Rigel Pharmaceuticals Inc  0.62 $ 276.785  Millions$ 445.451  Millions
Bioaffinity Technologies Inc   0.62 $ 5.901  Millions$ 9.518  Millions
Macrogenics Inc   0.61 $ 167.674  Millions$ 272.723  Millions
Tg Therapeutics Inc   0.61 $ 799.536  Millions$ 1,314.186  Millions
Heron Therapeutics Inc   0.60 $ 151.507  Millions$ 250.826  Millions
Akebia Therapeutics Inc   0.60 $ 219.060  Millions$ 363.224  Millions
10x Genomics Inc   0.60 $ 616.566  Millions$ 1,028.638  Millions
Sarepta Therapeutics Inc   0.60 $ 1,974.344  Millions$ 3,302.647  Millions
Heartflow Inc   0.60 $ 210.791  Millions$ 353.085  Millions
Pacira Biosciences inc   0.60 $ 746.164  Millions$ 1,253.752  Millions
Conmed Corporation  0.59 $ 1,371.657  Millions$ 2,315.871  Millions
Emergent Biosolutions Inc   0.59 $ 770.200  Millions$ 1,304.200  Millions
Globus Medical Inc   0.59 $ 3,144.934  Millions$ 5,331.554  Millions
Cvrx inc   0.59 $ 60.164  Millions$ 102.033  Millions
Skinhealth Systems Inc   0.59 $ 289.224  Millions$ 490.811  Millions
Solventum Corporation  0.59 $ 8,310.000  Millions$ 14,151.750  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.